Begun in 2017, the Project ALS Pre-Clinical Core (the Core) is the first rational, aggressive effort to rapidly and thoroughly test promising therapies for safety

The Core is the culmination of 20 years of Project ALS research achievements in genetics, stem cell research, and basic research studies. These breakthroughs allow

Project ALS was the first organization to use stem cells to model human ALS; this practice is now used worldwide. Project ALS scientists also use patient stem cells to screen for drugs.

Uplifting Athletes will honor Project ALS-funded Columbia University researcher Emily Lowry, PhD, with one of its first five Young Investigator Awards. Uplifting Athletes, a nonprofit

Meet Elizabeth Adelson, a neuroscience student at Yale University whom Project ALS will sponsor this summer, along with 4 other students, for a research internship

An exciting Project-ALS funded study on the involvement of the gene TDP-43 in ALS-frontotemporal dementia. Understanding how TDP-43 contributes to neurodegeneration will help direct therapeutic

The Project ALS Pre-Clinical Core at the Motor Neuron Center at Columbia University is the most recent effort to put drugs through rigorous testing—so that

New ALS gene is identified: Project ALS researchers play critical role in the identification of KIF5A, which gives scientists a better understanding of ALS and